Tocilizumab (Actemra) scores FDA approval for systemic sclerosis–associated interstitial lung diseaseMarch 5, 2021Pulmonology
Study clarifies who gets post–COVID-19 interstitial lung diseaseMarch 3, 2021COVID-19 UpdatesPulmonology
Asthma not an independent risk factor for severe COVID-19, hospitalizationFebruary 28, 2021AsthmaCOVID-19 UpdatesPulmonology
Prospective data support delaying antibiotics for pediatric respiratory infectionsFebruary 16, 2021Pulmonology
ColCORONA: More questions than answers for colchicine in COVID-19February 11, 2021COVID-19 UpdatesPulmonology
